PT—141-Bremelanotide-10mg-ml-4mL

Description

PT—141 (Bremelanotide) at 10mg/mL in a 4mL vial represents a breakthrough in therapeutic options for addressing hypoactive sexual desire disorder (HSDD) in both men and women. This peptide-based medication is uniquely designed to activate melanocortin receptors, which play a crucial role in enhancing sexual function independently of hormonal pathways. By addressing the root causes rather than symptoms, PT—141 empowers individuals to reclaim control over their well-being.

Lifestyle Compounding excels in providing precision-formulated pharmaceuticals like PT—141. With extensive experience in compounding, our team adheres to the highest standards of safety, purity, and efficacy. PT—141 is compounded to ensure optimal bioavailability and ease of use, reflecting our deep commitment to personalized medicine. Our pharmacists collaborate closely with healthcare providers to deliver targeted solutions tailored to patient needs.

Key Benefits of PT—141:

• Scientific Efficacy: Designed to treat HSDD without influencing systemic hormones.
• Fast Action: Administered via subcutaneous injection for rapid and effective results.
• Convenience & Safety: Compounded with precision for predictable dosing and minimal risk of contaminants.
• Broad Applicability: Suitable for use by both men and women, with proven clinical results.

Lifestyle Compounding’s expertise ensures that you receive PT—141 of the highest quality, prepared under strict regulatory compliance. We provide cutting-edge solutions in individualized care.

Adverse Reaction / Side Effects

While PT—141 is generally well-tolerated, some individuals may experience adverse effects. These can include:

• Mild to moderate nausea.
• Temporary skin flushing or discoloration at the injection site.
• Increased blood pressure in some cases.
• Headache or mild dizziness.

It is essential to consult a licensed healthcare practitioner before starting PT—141. Patients with pre-existing conditions such as uncontrolled hypertension or cardiovascular issues should disclose their medical history to ensure safe usage. Side effects are typically transient and resolve without intervention. Lifestyle Compounding recommends routine monitoring to optimize patient safety.

Storage

Correct storage is vital for maintaining the integrity and potency of PT—141. Follow these guidelines:

• Store the product refrigerated at temperatures between 2°C to 8°C (36°F to 46°F).
• Avoid exposure to direct sunlight, moisture, or extreme temperatures.
• Do not freeze the medication.
• Keep the vial sealed and protected from contaminants until ready for use.

For best results, always use PT—141 by its expiration date as indicated on the packaging. Should you have any concerns or questions about proper storage, Lifestyle Compounding’s team is available to assist.

References

1. Clinical Applications – Multiple clinical trials have evaluated the safety and efficacy of PT—141 (Bremelanotide) for the treatment of hypoactive sexual desire disorder (HSDD) and related dysfunctions in men and women. Notable studies published in peer-reviewed journals such as the Journal of Sexual Medicine and Current Medical Research and Opinion have demonstrated that PT—141, acting as a melanocortin receptor agonist, can significantly improve sexual desire and arousal with a favorable safety profile. For example, a pivotal Phase III trial (Simon JA et al., 2019) documented increased sexual responsiveness and satisfaction in premenopausal women with HSDD, with minimal impact on systemic hormones.
2. Pharmaceutical Standards – All compounded medications at Lifestyle Compounding, including PT—141, adhere strictly to guidelines outlined by the United States Pharmacopeia (USP), especially USP <795> (Pharmaceutical Compounding – Nonsterile Preparations) and USP <797> (Pharmaceutical Compounding – Sterile Preparations). These standards ensure aseptic technique, precise dosing, ingredient traceability, and rigorous quality assurance testing. Our facilities are regularly inspected and validated to maintain compliance with both federal and state regulatory requirements.
3. Patient-Centered Solutions – Lifestyle Compounding integrates patient-specific factors into the formulation and dispensing process for PT—141. For instance, dosing regimens can be customized based on patient tolerance and therapeutic goals, and educational support is provided to encourage adherence and monitor outcomes. Our pharmacists collaborate with prescribers to review patient histories, adjust treatment plans for comorbid conditions, and provide ongoing support, including telephone and telehealth consultations, ensuring the safe and optimal use of PT—141.

PT—141 Bremelanotide represents the forefront of innovation in compounding and pharmaceutical care. Delivered with precision and quality, it aligns perfectly with Lifestyle Compounding’s vision of transforming health through personalized medicine.